To date, over a billion adults and children around the world have received the Pfizer-BioNTech COVID-19 vaccine, which continues to demonstrate a favorable safety and efficacy profile supported by ...

Pfizer-BioNTech's COVID-19 vaccine, which was once hailed as a lifesaver, has been found to have subtle but serious side ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to 202 ...

Dan Peer, a global pioneer in mRNA drug development and director of the Laboratory of Precision NanoMedicine ... Research and Tel Aviv University is an mRNA-based vaccine delivered via lipid ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

AI also supports reverse vaccinology, where pathogen genomes are computationally analyzed to identify immunogenic regions ...

COVID-19 trends also depend on the emergence and spread of new variants. The latest, including NB.1.8.1, are getting better ...

Despite mistrust, Native Americans’ participation in vaccine development proves vital. ... the research on Pfizer’s COVID-19 vaccine included data on Native Americans’ reactions to the vaccine.